BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2165828)

  • 1. Heparin-stimulated inhibition of factor IXa generation and factor IXa neutralization in plasma.
    Pieters J; Lindhout T; Willems G
    Blood; 1990 Aug; 76(3):549-54. PubMed ID: 2165828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.
    Pieters J; Willems G; Hemker HC; Lindhout T
    J Biol Chem; 1988 Oct; 263(30):15313-8. PubMed ID: 3262615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of catalysis of inhibition of factor IXa by antithrombin in the presence of heparin or pentasaccharide.
    Wiebe EM; Stafford AR; Fredenburgh JC; Weitz JI
    J Biol Chem; 2003 Sep; 278(37):35767-74. PubMed ID: 12832413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
    Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
    Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The heparin-catalysed inhibition of human factor XIa by antithrombin III is dependent on the heparin type.
    Soons H; Tans G; Hemker HC
    Biochem J; 1988 Dec; 256(3):815-20. PubMed ID: 3265623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation and propagation of blood coagulation at artificial surfaces studied in a capillary flow reactor.
    Blezer R; Willems GM; Cahalan PT; Lindhout T
    Thromb Haemost; 1998 Feb; 79(2):296-301. PubMed ID: 9493579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of blood coagulation at heparin-coated surfaces.
    Blezer R; Fouache B; Willems GM; Lindhout T
    J Biomed Mater Res; 1997 Oct; 37(1):108-13. PubMed ID: 9335355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.
    Holmer E; Kurachi K; Söderström G
    Biochem J; 1981 Feb; 193(2):395-400. PubMed ID: 6914196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of heparin on the inactivation rate of human factor XIa by antithrombin-III.
    Scott CF; Schapira M; Colman RW
    Blood; 1982 Oct; 60(4):940-7. PubMed ID: 7115961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the acceleration of human factor XIa inactivation by antithrombin III.
    Scott CF; Colman RW
    Blood; 1989 May; 73(7):1873-9. PubMed ID: 2785417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites.
    Bedsted T; Swanson R; Chuang YJ; Bock PE; Björk I; Olson ST
    Biochemistry; 2003 Jul; 42(27):8143-52. PubMed ID: 12846563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
    Buyue Y; Misenheimer TM; Sheehan JP
    J Thromb Haemost; 2012 Oct; 10(10):2086-98. PubMed ID: 22905983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of a heparin binding site in the catalytic domain of factor XIa.
    Badellino KO; Walsh PN
    Biochemistry; 2001 Jun; 40(25):7569-80. PubMed ID: 11412111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
    Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
    J Biol Chem; 1980 Nov; 255(21):10081-90. PubMed ID: 6448846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin.
    Izaguirre G; Zhang W; Swanson R; Bedsted T; Olson ST
    J Biol Chem; 2003 Dec; 278(51):51433-40. PubMed ID: 14532267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depolymerized holothurian glycosaminoglycan with novel anticoagulant actions: antithrombin III- and heparin cofactor II-independent inhibition of factor X activation by factor IXa-factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin.
    Nagase H; Enjyoji K; Minamiguchi K; Kitazato KT; Kitazato K; Saito H; Kato H
    Blood; 1995 Mar; 85(6):1527-34. PubMed ID: 7888673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
    Sheehan JP; Kobbervig CE; Kirkpatrick HM
    Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of factor XIa by antithrombin III.
    Soons H; Janssen-Claessen T; Tans G; Hemker HC
    Biochemistry; 1987 Jul; 26(15):4624-9. PubMed ID: 3499176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
    Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of factor IXa with factor VIIIa. Effects of protease domain Ca2+ binding site, proteolysis in the autolysis loop, phospholipid, and factor X.
    Mathur A; Zhong D; Sabharwal AK; Smith KJ; Bajaj SP
    J Biol Chem; 1997 Sep; 272(37):23418-26. PubMed ID: 9287357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.